成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天
上海一飛生物科技有限公司 公司信息
公司名稱:
上海一飛生物科技有限公司
電話:
021-65675885
電子郵件:
customer_service@efebio.com
國籍:
中國
網(wǎng)址:
http://www.efebio.com
產(chǎn)品總數(shù):
11974
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
公司提供產(chǎn)品列表
Tilavonemab
TILAVONEMAB (替拉奈單抗 )
2096513-89-0
Spesolimab
司柏索利單抗
2097104-58-8
Garetosmab
GARETOSMAB (加托索單抗 )
2097125-54-5
Aneratrigine hydrochloride
ANERATRIGINE 鹽酸鹽
2097163-75-0
Pepinemab
PEPINEMAB (派比奈單抗 )
2097151-87-4
HBED-CC-tris(tert-butyl ester)
HBED-CC-TRIS(TERT-BUTYL ESTER)
2097123-80-1
Epcoritamab
EPCORITAMAB (艾可瑞妥單抗 )
2134641-34-0
I-138
化合物I-138
2098211-50-6
BCL6-IN-7
化合物 T8731
2097518-46-0
MLT-747
MLT-747
2097853-86-4
Stafib-2
化合物 STAFIB-2
2097938-74-2
Anatibant 2HCl
ANATIBANT二鹽酸鹽
209788-45-4
OBI-3424
OBI-3424
2097713-68-1
Zastaprazan
氮雜環(huán)丁烷-1-基(8-((2,6-二甲基芐基)氨基)-2,3-二甲基咪唑并[1,2-A]吡啶-6-基)甲酮
2133852-18-1
Canocapavir
化合物 CANOCAPAVIR
2137847-19-7
GSK3182571
GSK3182571
2135595-04-7
USP1-IN-2
化合物 USP1-IN-2
2098212-05-4
(-)-JNJ-A07
化合物 (-)-JNJ-A07
2135640-92-3
Nimacimab
NIMACIMAB (尼邁西單抗 )
2098636-09-8
Budigalimab
Budigalimab
2098225-93-3
Zampilimab
2098280-42-1
DN401
化合物DN401
2135749-60-7
SPOP-IN-6lc
SPOP抑制劑6LC
2136270-56-7
Disitamab vedotin
DISITAMAB VEDOTIN (緯迪西妥單抗 )
2136633-23-1
(+)-JNJ-A07
化合物 (+)-JNJ-A07
2135640-93-4
Maftivimab
MAFTIVIMAB (瑪替韋單抗 )
2135632-36-7
Odesivimab
ODESIVIMAB (奧西韋單抗 )
2135632-30-1
Betrixaban-d6
貝曲西班 D6
2098655-51-5
Atoltivimab
ATOLTIVIMAB (阿替韋單抗 )
2135632-29-8
Cantrixil
CANTRIXIL
2135511-22-5
Bis-PEG4-t-butyl ester
Bis-PEG4-t-butyl ester
2100306-53-2
CDK4/6/1 Inhibitor
CDK4/6/1 Inhibitor
2099128-41-1
Abelacimab
Abelacimab
2098724-83-3
3-OMFP Cyclohexylammonium salt
3-O-甲基熒光黃磷酸鹽單環(huán)己基銨鹽
21233-09-0
Glenzocimab
GLENZOCIMAB (格侖西單抗 )
2101829-58-5
Naph-EA-mal
NAPH-EA-MAL
210292-65-2
Duostatin 5
DUO-5
2124210-34-8
LY382884
3-Isoquinolinecarboxylic acid, 6-[(4-carboxyphenyl)methyl]decahydro-, (3S,4aR,6S,8aR)-
211566-75-5
Enpatoran hydrochloride
ENPATORAN HYDROCHLORIDE
2101945-93-9
Narsoplimab
NARSOPLIMAB (納索利單抗 )
2108782-45-0
Teclistamab
TECLISTAMAB (特立妥單抗 )
2119595-80-9
CM03
化合物 T23902
2101208-44-8
11-oxo-alpha-amyrin
ALPHA-香樹脂酮醇
2118-90-3
AT-121 hydrochloride
AT-121鹽酸
2099681-71-5
Elipovimab
ELIPOVIMAB (依帕韋單抗 )
2101210-43-7
Envafolimab
ENVAFOLIMAB (恩弗利單抗 )
2102192-68-5
Lodapolimab
LODAPOLIMAB (洛達(dá)利單抗 )
2118349-31-6
MK-6884
MK-6884
2102194-04-5
Telazorlimab
特拉佐利單抗
2126777-87-3
Se-DMC
化合物 SE-DMC
2098850-81-6
VU6000918
VU6000918
2101737-32-8
Lenumlostat
化合物L(fēng)ENUMLOSTAT
2098884-52-5
LFHP-1c
化合物 LFHP-1C
2102347-47-5
(R)-Pirtobrutinib
(R)-PIRTOBRUTINIB
2101700-14-3
Cephalexin-d5
頭孢氨芐-D5
2101505-56-8
Orexin 2 Receptor Agonist 2
OREXIN 2 RECEPTOR AGONIST 2
2114324-60-4
Sanguinarine citrate
血根堿檸檬酸鹽
2098782-69-3
Edonentan
Edonentan
210891-04-6
INT. 2
化合物INT. 2
210193-42-3
Taprizosin
N-{2-(4-Amino-6,7-dimethoxy-5-(2-pyridyl)quinazolin-2-yl)-1,2,3,4-tetrahydro-5-isoquinolyl}methanesulfonamide
210538-44-6
Benufutamab
BENUFUTAMAB (貝奴妥單抗 )
2109730-69-8
Fianlimab
FIANLIMAB (弗安利單抗 )
2126132-98-5
RAGE 229
化合物 RAGE 229
2143072-85-7
2-(3,4-Dihydroxyphenyl)-1,3-benzodioxole-5-carboxaldehyde
2-(3,4-Dihydroxyphenyl)-1,3-benzodioxole-5-carboxaldehyde
213903-67-4
DS28120313
DS28120313
2146177-09-3
Cendakimab
CENDAKIMAB (申達(dá)奇單抗 )
2151032-62-9
Cirtuvivint
CIRTUVIVINT
2143917-62-6
Prucalopride-13C-d3
普蘆卡必利雜質(zhì)
2140306-00-7
Aurora kinase inhibitor-8
化合物 AURORA KINASE INHIBITOR-8
2133001-88-2
MDH1-IN-2
化合物 MDH1-IN-2
2143463-35-6
SIRT5 inhibitor 3
化合物 SIRT5 INHIBITOR 3
2128651-12-5
CYP4A11/CYP4F2-IN-2
化合物CYP4A11/CYP4F2-IN-2
2126874-77-7
8-Azaguanosine
Azaguanosine
2133-80-4
BCL6-IN-8c
BCL6 inhibitor 8c
2130878-25-8
Serclutamab
SERCLUTAMAB (思諾妥單抗 )
2140172-41-2
Praluzatamab
PRALUZATAMAB (普羅妥單抗 )
2145109-70-0
MDH1-IN-1
化合物 MDH1-IN-1
2143463-31-2
Tetrahymanol
四膜蟲醇
2130-17-8
Plamotamab
PLAMOTAMAB (帕拉莫妥單抗 )
2138442-31-4
Pacmilimab
PACMILIMAB (帕克米利單抗 )
2145091-51-4
SC-75416
化合物 T28703
215122-74-0
Olaparib-d5
Olaparib D5
2143107-56-4
RIP1 kinase inhibitor 1
RIP1 KINASE INHIBITOR 1
2095515-38-9
Olinvacimab
Olinvacimab
2095504-49-5
L-Cysteine-d3
半胱氨酸
214782-32-8
YW2036
化合物 YW2036
2131223-92-0
(S)-ZINC-3573
10MG
2095596-11-3
AMPD2 inhibitor 1
AMPD2 inhibitor 1
2139356-35-5
Zalifrelimab
ZALIFRELIMAB (澤弗利單抗 )
2148321-69-9
Vibecotamab
VIBECOTAMAB (維克妥單抗 )
2138442-13-2
FmocNH-PEG4-t-butyl ester
N-芴甲氧羰基-四聚乙二醇-叔丁酯
2148295-94-5
Efalizumab
EFALIZUMABUM
214745-43-4
Boc-NH-PEG4-C2-Boc
氨基叔丁酯-四聚乙二醇-C2-叔丁酯
2138484-13-4
Bivatuzumab
比伐珠單抗
214559-60-1
MPT0G211
化合物 MPT0G211
2151853-97-1
Pozelimab
POZELIMAB (帕澤利單抗 )
2096328-94-6
Ocarocoxib
OCAROCOXIB
215122-22-8
Diayangambin
21453-68-9
Tidutamab
TIDUTAMAB (泰妥單抗 )
2148354-90-7
Daminozide-d6 (dimethyl-d6)
丁酰肼-D6
2140327-55-3
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
Copyright 2007? ChemicalBook. All rights reserved.